Astellas Pharma Share Holder Equity 2012-2025 | ALPMY

Astellas Pharma share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Astellas Pharma share holder equity for the quarter ending December 31, 2025 was $10.224B, a 18.75% decline year-over-year.
Astellas Pharma share holder equity for 2024 was $10.569B, a 6.78% decline from 2023.
Astellas Pharma share holder equity for 2023 was $11.338B, a 5.28% decline from 2022.
Astellas Pharma share holder equity for 2022 was $11.97B, a 4.15% decline from 2021.

Astellas Pharma Annual Share Holder Equity (Millions of US $)
2024	$10,569
2023	$11,338
2022	$11,970
2021	$12,488
2020	$11,827
2019	$11,337
2018	$11,965
2017	$11,355
2016	$10,451
2015	$11,993
2014	$12,315
2013	$11,298
2012	$12,416

Astellas Pharma Quarterly Share Holder Equity (Millions of US $)
2025-06-30	$10,224
2024-06-30	$10,729
2023-06-30	$11,522
2022-06-30	$11,851
2021-06-30	$12,584
2020-06-30	$12,152
2019-06-30	$11,372
2018-06-30	$11,738
2017-06-30	$11,877
2016-09-30	$12,027
2016-06-30	$11,072
2016-03-31	$10,451
2015-12-31	$10,843
2015-09-30	$10,849
2015-06-30	$10,937
2015-03-31	$11,993
2014-12-31	$12,093
2014-09-30	$12,434
2014-06-30	$12,053
2014-03-31	$12,315
2013-12-31	$11,604
2013-09-30	$11,339
2013-06-30	$11,002
2013-03-31	$11,298
2012-12-31	$12,930
2012-09-30	$12,742
2012-06-30	$12,301
2012-03-31	$12,416
2011-12-31	$12,818

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$29.805B	$12.558B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.845B	31.38
UCB SA (UCBJY)	Belgium	$60.713B	0.00
Takeda Pharmaceutical (TAK)	Japan	$57.538B	11.30
Zoetis (ZTS)	United States	$49.577B	18.36
Sandoz Group AG (SDZNY)	Switzerland	$37.136B	0.00
Otsuka Holdings, - (OTSKY)	Japan	$36.393B	14.73
BeOne Medicines - (ONC)	Switzerland	$33.976B	83.02
Daiichi Sankyo, - (DSNKY)	Japan	$33.284B	16.12
United Therapeutics (UTHR)	United States	$25.058B	20.49
Shionogi (SGIOY)	Japan	$18.069B	13.97
Merck (MKKGY)	Germany	$16.944B	11.65
IPSEN (IPSEY)	France	$16.273B	0.00
Summit Therapeutics (SMMT)	United States	$15.264B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.936B	27.96
Ionis Pharmaceuticals (IONS)	United States	$12.417B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.920B	0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$11.749B	16.23
Orion OYJ (ORINY)	Finland	$10.723B	18.62
Eisai (ESAIY)		$9.158B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.834B	16.35
Centessa Pharmaceuticals (CNTA)	United Kingdom	$6.102B	0.00
Grifols, S.A (GRFS)	Spain	$5.588B	0.00
Corcept Therapeutics (CORT)	United States	$4.458B	51.11
Crinetics Pharmaceuticals (CRNX)	United States	$4.130B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.094B	22.53
NewAmsterdam Pharma (NAMS)	Netherlands	$3.997B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.945B	16.50
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$3.838B	0.00
Indivior Pharmaceuticals (INDV)	United States	$3.724B	12.41
Hypermarcas (HYPMY)	Brazil	$3.308B	13.82
Dyne Therapeutics (DYN)	United States	$3.086B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.046B	9.86
Oruka Therapeutics (ORKA)	United States	$2.952B	0.00
Soleno Therapeutics (SLNO)	United States	$2.717B	228.83
Enliven Therapeutics (ELVN)	United States	$2.710B	0.00
Relay Therapeutics (RLAY)	United States	$2.670B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.479B	41.65
BioCryst Pharmaceuticals (BCRX)	United States	$2.398B	7.19
Nektar Therapeutics (NKTR)	United States	$2.223B	0.00
Definium Therapeutics (DFTX)	United States	$2.147B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.096B	19.46
Ocular Therapeutix (OCUL)	United States	$1.914B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.808B	0.00
Ardelyx (ARDX)	United States	$1.516B	0.00
Harrow (HROW)	United States	$1.338B	79.84
Savara (SVRA)	United States	$1.158B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.149B	5.37
Xeris Biopharma Holdings (XERS)	United States	$1.009B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.993B	0.00
Cronos Group (CRON)	Canada	$0.971B	0.00
Evotec AG (EVO)	Germany	$0.935B	0.00
Xencor (XNCR)	United States	$0.911B	0.00
Aktis Oncology (AKTS)	United States	$0.901B	0.00
Theravance Biopharma (TBPH)	United States	$0.842B	21.80
ARS Pharmaceuticals (SPRY)	United States	$0.799B	0.00
Relmada Therapeutics (RLMD)	United States	$0.765B	0.00
Bioventus (BVS)	United States	$0.753B	13.32
Ironwood Pharmaceuticals (IRWD)	United States	$0.592B	15.78
ProKidney (PROK)	United States	$0.589B	0.00
Esperion Therapeutics (ESPR)	United States	$0.557B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.556B	9.19
Rigel Pharmaceuticals (RIGL)	United States	$0.540B	4.49
Lyell Immunopharma (LYEL)	United States	$0.522B	0.00
Larimar Therapeutics (LRMR)	United States	$0.504B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.501B	0.00
Aquestive Therapeutics (AQST)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.487B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	21.37
Lexeo Therapeutics (LXEO)	United States	$0.443B	0.00
Altimmune (ALT)	United States	$0.422B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.409B	37.99
Century Therapeutics (IPSC)	United States	$0.404B	0.00
Akebia Therapeutics (AKBA)	United States	$0.375B	0.00
USANA Health Sciences (USNA)	United States	$0.334B	9.43
AleAnna (ANNA)	United States	$0.333B	124.75
Surrozen (SRZN)	United States	$0.324B	0.00
Siga Technologies (SIGA)	United States	$0.312B	14.06
Avalo Therapeutics (AVTX)	United States	$0.311B	0.00
Organogenesis (ORGO)	United States	$0.306B	8.81
Silence Therapeutics (SLN)	United Kingdom	$0.271B	0.00
Cybin (HELP)	Canada	$0.270B	0.00
Protara Therapeutics (TARA)	United States	$0.268B	0.00
Prelude Therapeutics (PRLD)	United States	$0.257B	0.00
Minerva Neurosciences (NERV)	United States	$0.238B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.230B	0.00
MediWound (MDWD)	Israel	$0.229B	0.00
Context Therapeutics (CNTX)	United States	$0.229B	0.00
Enlivex (ENLV)	Israel	$0.228B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.224B	0.00
Profound Medical (PROF)	Canada	$0.216B	0.00
OmniAb (OABI)	United States	$0.213B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.186B	0.00
Korro Bio (KRRO)	United States	$0.183B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.174B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.167B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.167B	0.00
Heron Therapeutics (HRTX)	United States	$0.161B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.154B	0.00
Avita Medical (RCEL)	United States	$0.154B	0.00
VAXART, INC (VXRT)	United States	$0.152B	10.50
Galectin Therapeutics (GALT)	United States	$0.151B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.147B	0.00
Journey Medical (DERM)	United States	$0.141B	0.00
Assertio Holdings (ASRT)	United States	$0.116B	0.00
Innate Pharma SA (IPHYF)	France	$0.115B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.107B	0.00
Pyxis Oncology (PYXS)	United States	$0.107B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Vivani Medical (VANI)	United States	$0.088B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.088B	0.00
PolyPid (PYPD)	Israel	$0.082B	0.00
Nuo Therapeutics (AURX)		$0.082B	0.00
Champions Oncology (CSBR)	United States	$0.080B	0.00
Gain Therapeutics (GANX)	United States	$0.076B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.073B	0.00
Fractyl Health (GUTS)	United States	$0.073B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.070B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
Dominari Holdings (DOMH)	United States	$0.065B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.049B	0.00
Nutriband (NTRB)	United States	$0.047B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.046B	34.33
SCYNEXIS (SCYX)	United States	$0.045B	0.00
Lite Strategy (LITS)	United States	$0.042B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.042B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Incannex Healthcare (IXHL)	Australia	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.033B	0.00
Tempest Therapeutics (TPST)	United States	$0.029B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
VYNE Therapeutics (VYNE)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Natural Alternatives (NAII)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Lipocine (LPCN)	United States	$0.016B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.014B	0.00
Wellgistics Health (WGRX)	United States	$0.014B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.014B	0.00
Scienture Holdings (SCNX)	United States	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Vivos Therapeutics (VVOS)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.012B	0.02
Ainos (AIMD)	United States	$0.012B	0.00
Cosmos Health (COSM)	United States	$0.011B	0.00
Mannatech (MTEX)	United States	$0.011B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
BioLineRx (BLRX)	Israel	$0.010B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.010B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.010B	0.00
Liminatus Pharma (LIMN)	United States	$0.008B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.008B	0.00
Inotiv (NOTV)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Xenetic Biosciences (XBIO)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.004B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.002B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
CDT Equity (CDT)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00